Stock Track | Doximity Plunges 8% Despite Strong Q2 Results as Growth Outlook Disappoints

Stock Track
2025/11/07

Doximity, Inc. (DOCS) experienced a significant 24-hour plunge of 8.12% on Thursday, despite reporting better-than-expected second-quarter financial results for fiscal 2026. The stark contrast between the company's strong performance and the market's negative reaction has left many investors puzzled.

In its Q2 report, Doximity announced revenue of $168.525 million, surpassing the estimated $156.8 million. The company's adjusted earnings per share (EPS) came in at $0.45, beating the consensus estimate of $0.38. Additionally, adjusted EBITDA reached $100.8 million, significantly higher than the expected $87.1 million. These results demonstrate Doximity's solid performance for the quarter ended September 30.

However, the company's forward guidance seems to have spooked investors. Doximity forecasts Q3 revenue between $180 million and $181 million, which is only in line with analyst expectations. For the full fiscal year, the company projects revenue in the range of $640-646 million. This outlook suggests a potential slowdown in growth, which appears to be the primary driver behind the stock's sharp decline. The market's reaction indicates concerns about Doximity's ability to maintain its growth trajectory in upcoming quarters, overshadowing its strong Q2 performance and triggering a sell-off in after-hours trading.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10